Type 2 Diabetes Mellitus
📧 Sign up to get email alerts when something new happens for Type 2 Diabetes Mellitus.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: Efficacy and Safety of Oral Semaglutide Versus Placebo in Subjects With Type 2 Diabetes Mellitus Treated With Insulin [Phase 3]
Phase 3 trial evaluating oral semaglutide versus placebo in people with type 2 diabetes treated with insulin; results completed and posted i…
-
CLINICAL_TRIALS trial_result · 2019-11-07Clinical Trial Update: Efficacy and Safety of Oral Semaglutide Versus Liraglutide and Versus Placebo in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial comparing oral semaglutide to liraglutide and placebo in type 2 diabetes, with completed status and posted results.
-
FDA approval · 2019-11-05FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Metformin hydrochloride from Macleods Pharmaceuticals Limited.
-
CLINICAL_TRIALS trial_result · 2019-11-05Clinical Trial Update: Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes [Phase 2]
Phase 2 trial assessing multiple-dose ranges of oral semaglutide in type 2 diabetes; results completed with efficacy data posted.
-
FDA approval · 2019-11-05FDA Approved: METFORMIN HYDROCHLORIDE — Supplemental Application (Macleods Pharmaceuticals Limited)
FDA approved a supplemental application for Metformin Hydrochloride from Macleods Pharmaceuticals Limited. The action approves an update to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2019-11-04Clinical Trial Update: A Phase 3, Randomized, Double-blind, Parallel-group, Comparative Study and a Phase 3, Multicenter, Open-label, Long-term Study of SYR-472 (25 mg) in Patients With Type 2 Diabetes Mellitus Complicated by Severe Renal Impairment or End-stage Renal Disease [Phase 3]
A Phase 3 randomized study and a long-term open-label study evaluating SYR-472 (25 mg) in patients with type 2 diabetes mellitus and severe …
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Role of Allopurinol on Oxidative Stress and Mitochondrial Alterations in Skeletal Muscle of Diabetic Patients [Phase 3]
Phase 3 trial investigating the role of allopurinol on oxidative stress and mitochondrial alterations in skeletal muscle of patients with ty…
-
CLINICAL_TRIALS trial_result · 2019-11-01Clinical Trial Update: Safety and Efficacy of SPIL1033 in Subjects With Type 2 Diabetes Mellitus [Phase 3]
Phase 3 trial update for SPIL1033 in type 2 diabetes mellitus reporting completed results.
-
CLINICAL_TRIALS trial_result · 2019-10-31Clinical Trial Update: Glycemic Response of Bean-and-rice Meals in Type 2 Diabetes Mellitus [Phase 2]
Phase 2 clinical trial update examining glycemic response to bean-and-rice meals in adults with type 2 diabetes mellitus.
-
FDA approval · 2019-10-30FDA Approved: GLYBURIDE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
The FDA approved a supplemental application for glyburide from Teva Pharmaceuticals USA, Inc., confirming approval of this generic product. …
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Ascending Doses of KQ-791 in Diabetes Mellitus [Phase 1]
Phase 1 trial update of KQ-791 in Type 2 diabetes assessing safety, tolerability, PK and PD across multiple ascending doses. Completed with …
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: An Investigation Into The Anti-hypertensive And Potential Anti-inflammatory Actions Of Dapagliflozin [Phase 4]
A Phase 4 clinical trial update investigating the anti-hypertensive and potential anti-inflammatory effects of dapagliflozin in type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Online WIC Nutrition Education to Promote Farmers' Market Fruit and Vegetable Purchases and Consumption [NA]
Clinical trial update on online nutrition education to promote fruit and vegetable purchases and consumption among participants; study statu…
-
CLINICAL_TRIALS trial_result · 2019-10-30Clinical Trial Update: Effect of 2-Week Nightly Moderate Hypoxia on Glucose Tolerance in Individuals With Type 2 Diabetes [NA]
A completed clinical trial assessing the impact of 2 weeks of nightly moderate hypoxia on glucose tolerance in individuals with type 2 diabe…
-
CLINICAL_TRIALS trial_result · 2019-10-29Clinical Trial Update: Treatment of Diabetes in Patients With Systolic Heart Failure [Phase 4]
Phase 4 clinical trial update on treating diabetes in patients with systolic heart failure; study completed with results posted in 2019.
-
FDA approval · 2019-10-28FDA Approved: REPAGLINIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for repaglinide submitted by Rising Pharma Holdings, Inc., resulting in changes to the drug's la…
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Study of Chiglitazar Compare With Sitagliptin in Type 2 Diabetes Patients [Phase 3]
A Phase 3 trial comparing chiglitazar with sitagliptin in type 2 diabetes patients has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-25Clinical Trial Update: Study of Chiglitazar Compare With Placebo in Type 2 Diabetes Patients [Phase 3]
Phase 3 clinical trial comparing chiglitazar to placebo in adults with type 2 diabetes has completed.
-
CLINICAL_TRIALS trial_result · 2019-10-22Clinical Trial Update: The Effect of Simple Basal Insulin Titration, Metformin Plus Liraglutide for Type 2 Diabetes With Very Elevated HbA1c - The SIMPLE Study [Phase 4]
Phase 4 trial updating the effects of simple basal insulin titration with metformin plus liraglutide in adults with type 2 diabetes and very…
-
FDA approval · 2019-10-21FDA Approved: FIASP — Supplemental Application (Novo Nordisk)
FDA approved a supplemental application for FIASP (insulin aspart injection) submitted by Novo Nordisk, updating the labeling.
-
CLINICAL_TRIALS trial_result · 2019-10-21Clinical Trial Update: Beta Cell Restoration Through Fat Mitigation [NA]
Clinical trial completed evaluating beta cell restoration through fat mitigation for prediabetes and type 2 diabetes; results posted in 2019…
-
CLINICAL_TRIALS research · 2019-10-21Clinical Trial Update: Effects of SGLT2 Inhibition Treatment on Different Levels of Albuminuria in Patients With Type 2 Diabetes [Phase 4]
A Phase 4 clinical trial evaluating the effects of SGLT2 inhibition on albuminuria levels in patients with type 2 diabetes and diabetic neph…
-
FDA approval · 2019-10-18FDA Approved: DAPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — Supplemental Application (Prasco Laboratories)
The FDA approved a supplemental application for a fixed-dose combination of dapagliflozin and metformin hydrochloride, submitted by Prasco L…
-
CLINICAL_TRIALS trial_result · 2019-10-18Clinical Trial Update: Insulin Sensitivity in Patients With Atopic Dermatitis
A completed clinical trial investigating insulin sensitivity in patients with atopic dermatitis and type 2 diabetes, with results posted in …
-
CLINICAL_TRIALS trial_result · 2019-10-15Clinical Trial Update: DBPR108 Tablets in Type 2 Diabetes Mellitus Patients [Phase 2]
A Phase 2 clinical trial update for DBPR108 tablets in patients with Type 2 Diabetes Mellitus has been completed.